David F. Lo, MS, BS

  • 5Articles
  • 196KReads
  • 2023–2024Active
  • 15Collaborators
  • 9Citations

About

David F. Lo, MS, BS, is affiliated with Rowan-Virtua School of Osteopathic Medicine and the American Preventive Screening and Education Association in Stratford, New Jersey, as well as the School of Arts and Sciences at Rutgers University. Since 2023, Lo has published research on topics including Body Dysmorphic Disorder, Complementary and Alternative Medicine, Multiple Sclerosis, and Psychedelics. His work covers clinical areas such as anabolic-androgenic steroid use related to body dysmorphia, hypersensitivity reactions to bupropion, therapeutic applications of theta burst stimulation in multiple sclerosis, and the mental health effects of psychedelic microdosing. Lo frequently collaborates with co-authors Hasan Zia, Ahmed Gawash, Christian P. White, Usmaan Al-Shehab, and Adarsh Thakur.

Publications

PCC
Unexpected Hypersensitivity to Bupropion
Case Report

Unexpected Hypersensitivity to Bupropion

December 5, 2024

A 33-year-old man with a history of depression presented to the emergency department with a rash 3 weeks after starting bupropion.
, , , et al
PCC
Impact of Theta Burst Stimulation on MS
Systematic Review

Impact of Theta Burst Stimulation on MS

April 18, 2024

Theta burst stimulation interventions may hold promise in addressing specific multiple sclerosis symptoms, notably fatigue and spasticity.
, , , et al
PCC
Psychedelic Microdosing and Mental Health
Systematic Review

Psychedelic Microdosing and Mental Health

January 16, 2024

There is a growing body of evidence suggesting a positive correlation between psychedelic microdosing and improved mental well-being.
, , , et al
PCC
[RETRACTED] Body Dysmorphia, Steroid Use, and Mental Health
Systematic Review

[RETRACTED] Body Dysmorphia, Steroid Use, and Mental Health

October 24, 2023

Steroid use is associated with many detrimental effects on mental health, including a higher risk of developing symptoms of psychosis, depression, anxiety, and aggression.
, , , et al

Physicians Postgraduate Press, Inc. (PPP) makes no warranties about the accuracy or completeness of any information published in The Journal of Clinical Psychiatry or other PPP materials, and disclaims liability for any use or non-use of that information. Clinicians should not rely solely on these materials and should exercise their own professional judgment when making patient care decisions on an individualized basis.

Learn More About Psychedelics in Psychiatry

Explore the Collection
Neural network illustration symbolizing psychedelic research advancements

Subscribe to read
more articles

Subscribe